Nina Tandon

Nina Tandon is an electrical engineer, entrepreneur, and biomedical researcher known for work in tissue engineering, biotechnology commercialization, and science communication. She co-founded a biotechnology company focused on engineered cardiac and musculoskeletal tissues, has lectured at academic institutions and conferences, and has been recognized by business and science organizations for innovation at the interface of engineering, medicine, and entrepreneurship.

Early life and education

Born to an academic family, Tandon studied engineering and life sciences, completing undergraduate and graduate studies at institutions associated with Columbia University, Massachusetts Institute of Technology, New York University, and University of Pennsylvania networks through collaborations and research appointments. Her formative mentors and collaborators included faculty linked to Johns Hopkins University, Harvard University, Stanford University, Princeton University, and Yale University. During her doctoral and postdoctoral training she worked in laboratories connected with National Institutes of Health, Howard Hughes Medical Institute, National Science Foundation, and clinical partners such as NewYork-Presbyterian Hospital and Mount Sinai Health System. Early influences also included exposure to research environments affiliated with Brookhaven National Laboratory, Cold Spring Harbor Laboratory, Salk Institute, and European centers like Max Planck Society and ETH Zurich.

Career

Tandon co-founded and led a biotechnology company that attracted attention from investors, accelerators, and corporate partners including organizations such as Y Combinator, Techstars, Sequoia Capital, Andreessen Horowitz, and industry collaborators tied to Pfizer, Johnson & Johnson, Roche, and Medtronic. She has delivered invited talks at venues including TED Conference, Aspen Ideas Festival, World Economic Forum, SXSW, and academic symposia at Royal Society, National Academy of Sciences, American Association for the Advancement of Science, and IEEE. Her entrepreneurial activity connected her with startup ecosystems in Silicon Valley, New York City, Boston, and Cambridge, United Kingdom, and with incubators such as Massachusetts Institute of Technology Media Lab, Harvard Innovation Labs, and Stanford d.school.

Research and contributions

Tandon’s research centered on electrically conductive scaffolds, engineered myocardium, and bioreactor systems, linking concepts developed at MIT Koch Institute, Harvard Wyss Institute, Wyss Institute for Biologically Inspired Engineering, Harvard-MIT Health Sciences and Technology, and the Broad Institute. She published and presented work on cardiac tissue maturation, skeletal muscle engineering, and stem cell-derived cardiomyocytes, in contexts related to groups at Columbia University Irving Medical Center, Weill Cornell Medicine, Icahn School of Medicine at Mount Sinai, and UCSF. Her translational focus engaged regulatory and clinical entities including U.S. Food and Drug Administration, European Medicines Agency, American College of Cardiology, and Society for Biomaterials. Collaborative projects linked to investigators at University of California, Berkeley, University of Michigan, Penn Medicine, Mayo Clinic, and Cleveland Clinic broadened applications toward disease modeling, drug screening, and implantable tissues. Techniques and platforms she advanced intersected with technologies from CRISPR-Cas9 research groups, organ-on-chip initiatives at Wyss Institute, and biomaterials efforts at Lawrence Berkeley National Laboratory, incorporating measurement methods influenced by labs at Sandia National Laboratories and Los Alamos National Laboratory.

Awards and honors

Her awards and recognitions included honors from entrepreneurial and scientific institutions such as Forbes, Fast Company, TIME, Smithsonian Institution, National Academy of Engineering-affiliated programs, and accelerator distinctions from Kauffman Foundation and Bill & Melinda Gates Foundation-supported competitions. She was profiled by media outlets including The New York Times, The Wall Street Journal, The Washington Post, BBC, and NPR, and received speaking invitations from TEDx, Royal Institution, and American Heart Association conferences. Professional fellowships and prizes brought connections to Harvard Business School, Wharton School, INSEAD, Oxford University Said Business School, and leadership networks such as World Economic Forum Young Global Leaders and Aspen Institute.

Personal life and public engagement

Beyond the laboratory, she engaged with public science initiatives and educational outreach associated with institutions like Smithsonian Institution exhibits, American Museum of Natural History programs, and science festivals coordinated by European Commission and National Science Foundation. Her public-facing work included mentorship through organizations such as Girl Scouts of the USA, Girls Who Code, Khan Academy, and university outreach programs at Columbia University and NYU Tandon School of Engineering. She participated in policy and advocacy forums alongside representatives from U.S. Congress, United Nations, World Health Organization, and nongovernmental organizations including Bill & Melinda Gates Foundation and Wellcome Trust. Personal associations connected her with professional societies like American Institute for Medical and Biological Engineering, Biomedical Engineering Society, Institute of Electrical and Electronics Engineers, and community initiatives in New York City and Boston.

Category:Biomedical engineers Category:Entrepreneurs